| HSC Source | Peripheral Blood | Umbilical Cord | Bone Marrow | |||
| No. | % | No. | % | No. | % | |
| Patients | 23 | 85.18 | 3 | 11.11 | 1 | 3.7 |
| Age, y.m (range) | 9.6 (0.5 - 18.7) | 5.3 (0.4 - 13.2) | 17.4 | |||
| Sex, Male/female | 16/7 | 42737 | 0/1 | |||
| Underlying disease, n | ||||||
| ・ Hematologic malignancies | 16 | 1 | 1 | |||
| ・ Primary Immunodeficiency Diseases | 6 | 2 | 0 | |||
| ・ Other | 1 | 0 | 0 | |||
| Total-body irradiation | 8 | 1 | 1 | |||
| Donor/recipient Female/male | 9 | 0 | 0 | |||
| Cell dose (Mean) | 9 × 106/kg (2.5 - 14.6) | 8.8 × 105/kg (4.4 - 13.3) | 1.48 × 106 /kg | |||
| Infection 3 months prior to allogeneic transplant, n | 7 | 1 | 0 | |||
| Donor, n | ||||||
| ・ HLA-identical related | 14 | 0 | 1 | |||
| ・ HLA-matched unrelated | 0 | 3 | 0 | |||
| ・ HLA-identical unrelated | 1 | 0 | 0 | |||
| ・ Haploidentical | 4 | 0 | 0 | |||
| Bacteremia within the first 7 days post-transplant, n | 10 | 2 | 0 | |||
| CMV infection in the recipient n | 4 | 0 | 0 | |||